Clinical Trials Logo

Laparoscopic Sleeve Gastrectomy clinical trials

View clinical trials related to Laparoscopic Sleeve Gastrectomy.

Filter by:

NCT ID: NCT03435003 Completed - Clinical trials for Laparoscopic Sleeve Gastrectomy

Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy

Start date: August 28, 2017
Phase: Phase 4
Study type: Interventional

Bariatric surgery remains the most effective therapy for obesity. Postoperative nausea and vomiting (PONV) are commonly reported following bariatric surgery. The proposed study focuses on the most common bariatric procedure performed, laparoscopic sleeve gastrectomy (LSG), and aims to assess the effect of a post-operative nausea and vomiting-specific intervention. The investigators hypothesize that the intervention group will experience a reduction of nausea-related prolonged hospital stay and significantly improve patient-reported quality of recovery from surgery and quality of life.

NCT ID: NCT03051919 Completed - Clinical trials for Laparoscopic Sleeve Gastrectomy

Reinforcement Method in Laparoscopic Sleeve Gastrectomy

Start date: March 2014
Phase: N/A
Study type: Observational

Laparoscopic sleeve gastrectomy is a technically simple popular bariatric operation with acceptable results. Leaks can occur in long staple lines; therefore, variable reinforcement methods are used.

NCT ID: NCT02762487 Terminated - Obesity Clinical Trials

RELIEF Europe Study

Start date: November 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the LINX device in patients who have previously undergone laparoscopic sleeve gastrectomy (LSG) for obesity and have chronic gastroesophageal reflux disease (GERD). The study will monitor safety and changes in reflux symptoms.

NCT ID: NCT02008409 Withdrawn - Clinical trials for Laparoscopic Sleeve Gastrectomy

Evaluation of Safety and Efficacy of the EndoLift Liver Retractor

Start date: November 2011
Phase: N/A
Study type: Interventional

The primary goal of the study is to evaluate the safety of the EndoLift Liver Retractor as an internal laparoscopic liver retraction device. The secondary goals of the study are to evaluate the efficacy of the EndoLift Liver Retractor as an internal laparoscopic liver retraction device and to identify 'best practices' for device utilization. This study evaluates the use of a specific type of liver retractor (EndoLift). Liver retractors are often necessary during MIS procedures, but this retractor is the only device which is deployed internally (NOT requiring additional skin punctures/incisions for placement of the liver retractor device). All patients undergoing minimally invasive surgery (MIS) at Duke Regional Hospital will be approached. The new device is expected to have a minimal risk safety profile. The investigators believe that these risks are no more than would be encountered by using any other commercially available retraction device available on the market today. Data will be collected and analyzed by the identified investigators. Continuous variables will be analyzed via T-test and Chi-square analysis will be applied to discontinuous variables. Statistical analysis software such as SPSS® will be utilized when necessary.